Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Gastrointestinal 1

Conditions

Neoplasm Metastasis 9Colorectal Neoplasms 8Rectal Neoplasms 7Liver Neoplasms 7Carcinoma, Hepatocellular 7Colonic Neoplasms 6Rhabdomyosarcoma 4Hepatoblastoma 4Wilms Tumor 3Sarcoma, Ewing 3Sarcoma 3Rhabdoid Tumor 3Retinoblastoma 3Neuroblastoma 3Melanoma 3Medulloblastoma 3Central Nervous System Neoplasms 3Carcinoma, Renal Cell 3Uveal Melanoma 2Pancreatic Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Kidney Neoplasms 2Hyperthermia 2Carcinoma, Islet Cell 2Brain Neoplasms 2Astrocytoma 2Appendiceal Neoplasms 2Vipoma 1Testicular Neoplasms 1

Interventions

montanide ISA 51 1detox adjuvant 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1Melphalan 1Magnetic Resonance Spectroscopy 1Leucovorin 1Interleukin-2 1Floxuridine 1Diagnostic Tests, Routine 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Diseases, Inborn × Melphalan × Gastrointestinal × Clear all
NCT00019760 2023-10-31

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡